Final ID:
Kittleson Michelle, Mauer Matthew
Updated Phase 1 Clinical Trial Outcomes of CRISPR Gene Editing With Nexiguran Ziclumeran In Patients With Transthyretin Amyloidosis With CardiomyopathyGillmore Julian, Smith Derek, Haagensen Alexandra, Olbertz Joy, Zhu Peijuan, Boiselle Carri, Leung Adia, Gutstein David, Sonderfan Alison, Walsh Liron, Fontana Marianna, Solomon Scott, Taubel Jorg, Gane Edward, Pilebro Bjorn, Adams David, Claggett Brian, Kachadourian Jessica, Rocha Ricardo